At CES 2023, the CEO of Moderna discussed mRNA technology.
The Covid-19 pandemic continues to be a terrible plight on the world. But if there’s any silver lining in what has happened, the deadly worldwide plague has brought about advancements in medicine created to fight it that may have transformational impacts well past the pandemic.
In a conversation during CES 2023, one of the world’s eminent tech gatherings, Moderna CEO Stéphane Bancel discussed the potential to utilize mRNA technology at the basis of groundbreaking Covid vaccines, developed with unprecedented speed, to create personalized cancer treatments.
Yuuji/iStock.
In a conversation during CES 2023, one of the world’s eminent tech gatherings, Moderna CEO Stéphane Bancel discussed the potential to utilize mRNA technology at the basis of groundbreaking Covid vaccines, developed with unprecedented speed, to create personalized cancer treatments. The conversation “Personalized Medicine: The Future of Cancer Treatment is Not One-Size Fits All” was led by Stephen Klasko, executive in residence at General Catalyst and advisor at Stel Life.
Comments are closed.